MTN 003D

An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial

Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID)
US National Institutes of Health (NIH)

Protocol Summary: MTN 003D is a qualitative exploratory study examining the larger contextual issues and specific aspects of MTN 003 (VOICE) that positively and negatively affected participants’ actual and reported product use.

Years: 2012 – 2014

Investigator: Z.M. Chirenje, MD, FRCOG

Locations: Seke South and Zengeza CRSs

MTN

Completed Study

Publication:

van der Straten A, Montgomery ET, Musara P, et al. (2015) Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015 Oct 23;29(16): 2161-71.

Musara P, Montgomery ET, Mgodi NM, et al. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda, and Zimbabwe. AIDS Behav. 2017 Jan 21.

Comments are closed.

Website by Canton Becker